No Data
Express News | Marker Therapeutics Inc Files for Resale of up to 10.1 Mln Shares by the Selling Stockholders - SEC Filing
Insider Purchase: 10% Owner at $MRKR (MRKR) Buys 554,250 Shares
Marker Therapeutics Sees $1.77 Million Stock Acquisition by Investors
Marker Therapeutics Shares Are Trading Lower. The Company Reported Results From Its Phase 1 APOLLO Study of MT-601 in Relapsed Lymphoma.
Express News | Marker Therapeutics Inc - MT-601 Well Tolerated With No Icans Observed
Marker Therapeutics Announces $16.1 Million Private Placement
No Data
Lnova : wow that’s frustrating, that news catalyst seemed really good
Trytosaveabit OP Lnova : Yup! Grrr